Advertisement

Integrative Review of Reproductive Decision Making of Women Who Are BRCA Positive

Published:September 11, 2020DOI:https://doi.org/10.1016/j.jogn.2020.07.006

      Abstract

      Objective

      To synthesize research findings about reproductive decision making among women who are BRCA positive.

      Data Sources

      PubMed and CINAHL.

      Study Selection

      Articles published in English between 2000 and June 28, 2020, about the reproductive decision making of women with a confirmed BRCA1 or BRCA2 mutation.

      Data Extraction

      We extracted data about participants, study design, analysis, follow-up, and results. We used the modified Downs and Black checklist and Kennelly’s qualitative data analysis to rate studies for quality and applicability by using.

      Data Synthesis

      We included five of 257 screened articles in our synthesis. The total sample size of the five studies was 1,468 women. The most prevalent factors related to reproductive decision making were the impending decisions regarding childbearing and family choices, including decisions about biological children, preventive surgery, preimplantation genetic diagnosis, and prenatal diagnosis to prevent further transmission of a BRCA mutation, and family planning.

      Conclusion

      A lack of knowledge exists about the reproductive decision-making processes of women who are BRCA positive. A better understanding of this process would provide nurses and other clinicians with the knowledge needed to support these women through their reproductive life choices.

      Keywords

      To read this article in full you will need to make a payment
      AWHONN Member Login
      AWHONN Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Gynecology, American College of Obstetricians and Gynecologists Committee on Genetics, & Society of Gynecologic Oncology
        Practice bulletin no. 182: Hereditary breast and ovarian cancer syndrome.
        Obstetrics & Gynecology. 2017; 130: e110-e126https://doi.org/10.1097/AOG.0000000000002296
        • American Nurses Association
        Essential competencies. In Essentials of genetic and genomic nursing: Competencies, curricula guidelines, and outcome indicators.
        2nd ed. 2016: 11-13
        • Bayefsky M.
        Who should regulate preimplantation genetic diagnosis in the United States?.
        AMA Journal of Ethics. 2018; 20: E1160-E1167https://doi.org/10.1001/amajethics.2018.1160
        • Chan J.L.
        • Johnson L.N.C.
        • Sammel M.D.
        • DiGiovanni L.
        • Voong C.
        • Domchek S.M.
        • Gracia C.R.
        Reproductive decision-making in women with BRCA1/2 mutations.
        Journal of Genetic Counseling. 2017; 26: 594-603https://doi.org/10.1007/s10897-016-0035-x
        • Daly M.B.
        • Pilarski R.
        • Berry M.
        • Buys S.S.
        • Farmer M.
        • Friedman S.
        • Darlow S.
        NCCN guidelines insights: Genetic/familial high-risk assessment: Breast and ovarian, version 2.2017.
        Journal of the National Comprehensive Cancer Network. 2017; 15: 9-20https://doi.org/10.6004/jnccn.2017.0003
        • Dean M.
        • Rauscher E.A.
        “It was an emotional baby”: Previvors’ family planning decision-making styles about hereditary breast and ovarian cancer risk.
        Journal of Genetic Counseling. 2017; 26: 1301-1313https://doi.org/10.1007/s10897-017-0069-8
        • Derks-Smeets I.A.
        • Gietel-Habets J.J.
        • Tibben A.
        • Tjan-Heijnen V.C.
        • Meijer-Hoogeveen M.
        • Geraedts J.P.
        • van Osch L.A.
        Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: A challenge for couples with hereditary breast and ovarian cancer.
        Human Reproduction. 2014; 29: 1103-1112https://doi.org/10.1093/humrep/deu034
        • Di Prospero L.S.
        • Seminsky M.
        • Honeyford J.
        • Doan B.
        • Franssen E.
        • Meschino W.
        • Warner E.
        Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: Findings from a focus group and a needs-assessment survey.
        Canadian Medical Association Journal. 2001; 164: 1005-1009
        • Donnelly L.S.
        • Watson M.
        • Moynihan C.
        • Bancroft E.
        • Evans D.G.
        • Eeles R.
        • Ormondroyd E.
        Reproductive decision-making in young female carriers of a BRCA mutation.
        Human Reproduction. 2013; 28: 1006-1012https://doi.org/10.1093/humrep/des441
        • Downs S.
        • Black N.
        The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions.
        Journal of Epidemiology and Community Health. 1998; 52: 377-384https://doi.org/10.1136/jech.52.6.377
        • Drazba K.T.
        • Kelley M.A.
        • Hershberger P.E.
        A qualitative inquiry of the financial concerns of couples opting to use preimplantation genetic diagnosis to prevent the transmission of known genetic disorders.
        Journal of Genetic Counseling. 2014; 23: 202-211https://doi.org/10.1007/s10897-013-9638-7
        • Farland L.V.
        • Missmer S.A.
        • Rich-Edwards J.
        • Chavarro J.E.
        • Barbieri R.L.
        • Grodstein F.
        Use of fertility treatment modalities in a large United States cohort of professional women.
        Fertility and Sterility. 2014; 101: 1705-1710https://doi.org/10.1016/j.fertnstert.2014.03.016
        • Flink D.M.
        • Sheeder J.
        • Kondapalli L.A.
        A review of the oncology patient’s challenges for utilizing fertility preservation services.
        Journal of Adolescent and Young Adult Oncology. 2017; 6: 31-44https://doi.org/10.1089/jayao.2015.0065
        • Fortuny D.
        • Balmaña J.
        • Graña B.
        • Torres A.
        • Ramón y Cajal T.
        • Darder E.
        • Brunet J.
        Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
        Human Reproduction. 2009; 24: 1000-1006https://doi.org/10.1093/humrep/den471
        • Friedman L.C.
        • Kramer R.M.
        Reproductive issues for women with BRCA mutations.
        Journal of the National Cancer Institute Monographs. 2005; 2005: 83-86https://doi.org/10.1093/jncimonographs/lgi012
        • Garcia C.
        • Lyon L.
        • Littell R.D.
        • Powell C.B.
        Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations.
        Genetics in Medicine. 2014; 16: 896-902https://doi.org/10.1038/gim.2014.48
        • Garcia C.
        • Wendt J.
        • Lyon L.
        • Jones J.
        • Littell R.D.
        • Armstrong M.A.
        • Powell C.B.
        Risk management options elected by women after testing positive for a BRCA mutation.
        Gynecologic Oncology. 2014; 132: 428-433https://doi.org/10.1016/j.ygyno.2013.12.014
        • Gietel-Habets J.J.
        • de Die-Smulders C.E.M.
        • Derks-Smeets I.A.P.
        • Tibben A.
        • Tjan-Heijnen V.C.G.
        • van Golde R.
        • van Osch L.A.D.M.
        Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
        Human Reproduction. 2017; 32: 588-597https://doi.org/10.1093/humrep/dew352
        • Greco K.E.
        • Tinley S.
        • Seibert D.
        Development of the essential genetic and genomic competencies for nurses with graduate degrees.
        Annual Review of Nursing Research. 2011; 29: 173-190https://doi.org/10.1891/0739-6686.29.173
        • Green V.L.
        • Weiss P.M.
        Breast disorders, an issue of obstetric and gynecology clinics.
        Clinics Review Articles. 2013; 40
        • Hamilton R.
        • Hurley K.E.
        Conditions and consequences of a BRCA mutation in young, single women of childbearing age.
        Oncology Nursing Forum. 2010; 37: 627-634https://doi.org/10.1188/10.ONF.627-634
        • Heald B.
        • Marquard J.
        • Funchain P.
        Strategies for clinical implementation of screening for hereditary cancer syndromes.
        Seminars in Oncology. 2016; 43: 609-614https://doi.org/10.1053/j.seminoncol.2016.08.008
        • Herlihy N.S.
        • Sekhon L.
        • Lee J.A.
        • Stein D.
        • Copperman A.
        • Lederman M.A.
        Caring for BRCA carriers: Strategies to promote health and preserve fertility.
        Journal of Women’s Health and Gynecology. 2018; 5: 101https://doi.org/10.17303/jwhg.2018.5.101
        • Hesse-Biber S.
        The genetic testing experience of BRCA-positive women: Deciding between surveillance and surgery.
        Qualitative Health Research. 2014; 24: 773-789https://doi.org/10.1177/1049732314529666
        • Hesse-Biber S.
        • An C.
        Genetic testing and post-testing decision making among BRCA-positive mutation women: A psychosocial approach.
        Journal of Genetic Counseling. 2016; 25: 978-992https://doi.org/10.1007/s10897-015-9929-2
        • Hoskins L.M.
        • Werner-Lin A.
        • Greene M.H.
        In their own words: Treating very young BRCA1/2 mutation-positive women with care and caution.
        PLOS ONE. 2014; 9 (Article e87696)https://doi.org/10.1371/journal.pone.0087696
        • Howard A.F.
        • Balneaves L.G.
        • Bottorff J.L.
        Women’s decision making about risk-reducing strategies in the context of hereditary breast and ovarian cancer: A systematic review.
        Journal of Genetic Counseling. 2009; 18: 578-597https://doi.org/10.1007/s10897-009-9245-9
        • Insogna I.G.
        • Ginsburg E.
        Transferring embryos with indeterminate PGD results: The ethical implications.
        Fertility Research and Practice. 2016; 2 (Article 2)https://doi.org/10.1186/s40738-016-0014-9
        • Insogna I.G.
        • Ginsburg E.S.
        • Partridge A.H.
        Fertility preservation in BRCA carriers: Special considerations.
        in: Chagpar A.B. Managing BRCA mutation carriers (Vol. 1, p. 242). Springer International Publishing, 2017
        • Julian-Reynier C.
        • Fabre R.
        • Coupier I.
        • Stoppa-Lyonnet D.
        • Lasset C.
        • Caron O.
        • Nogues C.
        BRCA1/2 carriers: Their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
        Genetics in Medicine. 2012; 14: 527-534https://doi.org/10.1038/gim.2011.27
        • Kennelly J.
        Methodological approach to assessing the evidence.
        in: Handler A. Kennelly J. Peacock N. Reducing racial/ethnic disparities in reproductive and perinatal outcomes: The evidence from population-based interventions (pp. 7–19). Springer, 2011https://doi.org/10.1007/978-1-4419-1499-6_2
        • Kim J.
        • Skrzynia C.
        • Mersereau J.E.
        A pilot study of BRCA mutation carriers’ knowledge about the clinical impact of prophylactic-oophorectomy and views on fertility consultation: A single-center pilot study.
        Journal of Genetic Counseling. 2015; 24: 149-157https://doi.org/10.1007/s10897-014-9747-y
        • Kridli S.A.-O.
        • Austin H.
        Factors influencing women’s decisions to getting tested for BRCA mutation.
        Journal of Nursing Education and Practice. 2018; 9: 33-39https://doi.org/10.5430/jnep.v9n3p33
        • Kuchenbaecker K.B.
        • Hopper J.L.
        • Barnes D.R.
        • Phillips K.-A.
        • Mooij T.M.
        • Roos-Blom M.-J.
        • Antoniou A.C.
        Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.
        Journal of the American Medical Association. 2017; 317: 2402-2416https://doi.org/10.1001/jama.2017.7112
        • Lin W.
        • Titus S.
        • Moy F.
        • Ginsburg E.S.
        • Oktay K.
        Ovarian aging in women with BRCA germline mutations.
        Journal of Clinical Endocrinology and Metabolism. 2017; 102: 3839-3847https://doi.org/10.1210/jc.2017-00765
        • Mor P.
        • Brennenstuhl S.
        • Metcalfe K.A.
        Uptake of preimplantation genetic diagnosis in female BRCA1 and BRCA2 mutation carriers.
        Journal of Genetic Counseling. 2018; 27: 1386-1394https://doi.org/10.1007/s10897-018-0264-2
        • National Cancer Institute
        BRCA mutations: Cancer risk and genetic testing.
        • National Comprehensive Cancer Network
        NCCN clinical practice guidelines in oncology: Genetic/familial high-risk assessment: Breast and ovarian, version 3.2019.
        2019 (https://www.nccn.org/professional/physician_gls/pdf/genetics_screening.pdf)
        • Nelson H.D.
        • Pappas M.
        • Cantor A.
        • Haney E.
        • Holmes R.
        Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: Updated evidence report and systematic review for the US Preventive Services Task Force.
        Journal of the American Medical Association. 2019; 322: 666-685https://doi.org/10.1001/jama.2019.8430
        • Ormondroyd E.
        • Donnelly L.
        • Moynihan C.
        • Savona C.
        • Bancroft E.
        • Evans D.G.
        • Watson M.
        Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: A qualitative analysis.
        European Journal of Human Genetics. 2012; 20: 4-10https://doi.org/10.1038/ejhg.2011.146
        • Padamsee T.J.
        • Wills C.E.
        • Yee L.D.
        • Paskett E.D.
        Decision making for breast cancer prevention among women at elevated risk.
        Breast Cancer Research. 2017; 19 (Article 34)https://doi.org/10.1186/s13058-017-0826-5
        • Pal T.
        • Bonner D.
        • Cragun D.
        • Monteiro A.N.
        • Phelan C.
        • Servais L.
        • Vadaparampil S.T.
        A high frequency of BRCA mutations in young Black women with breast cancer residing in Florida.
        Cancer. 2015; 121: 4173-4180https://doi.org/10.1002/cncr.29645
        • Pellegrini I.
        • Prodromou N.
        • Coupier I.
        • Huiart L.
        • Moretta J.
        • Nogues C.
        • Julian-Reynier C.
        Having a child and PND/PGD access in women with a BRCA1/2 mutation? Different approach whether ill or healthy.
        Bulletin du Cancer. 2014; 101: 1001-1008https://doi.org/10.1684/bdc.2014.2036
        • Quinn G.P.
        • Vadaparampil S.T.
        • Tollin S.
        • Miree C.A.
        • Murphy D.
        • Bower B.
        • Silva C.
        BRCA carriers’ thoughts on risk management in relation to preimplantation genetic diagnosis and childbearing: When too many choices are just as difficult as none.
        Fertility and Sterility. 2010; 94: 2473-2475https://doi.org/10.1016/j.fertnstert.2010.03.064
        • Rubin L.R.
        • Werner-Lin A.
        • Sagi M.
        • Cholst I.
        • Stern R.
        • Lilienthal D.
        • Hurley K.
        ‘The BRCA clock is ticking!’: Negotiating medical concerns and reproductive goals in preimplantation genetic diagnosis.
        Human Fertility. 2014; 17: 159-164https://doi.org/10.3109/14647273.2014.940003
        • Sankar P.
        • Wolpe P.R.
        • Jones N.L.
        • Cho M.
        How do women decide? Accepting or declining BRCA1/2 testing in a nationwide clinical sample in the United States.
        Community Genetics. 2006; 9: 78-86https://doi.org/10.1159/000091484
        • Society of Gynecologic Oncology
        Hereditary breast and ovarian cancer syndrome. Practice bulletin number 182.
        Obstetrics and Gynecology. 2017; 130 (https://doi.org/10.1097/AOG.0000000000002285): e110-e126
        • Stan D.L.
        • Shuster L.T.
        • Wick M.J.
        • Swanson C.L.
        • Pruthi S.
        • Bakkum-Gamez J.N.
        Challenging and complex decisions in the management of the BRCA mutation carrier.
        Journal of Women’s Health. 2013; 22: 825-834https://doi.org/10.1089/jwh.2013.4407
        • Stopfer J.
        How to tell your family about your BRCA gene mutation.
        Focus on Cancer. 2012;
        • Tung N.M.
        • Boughey J.C.
        • Pierce L.J.
        • Robson M.E.
        • Bedrosian I.
        • Dietz J.R.
        • Zakalik D.
        Management of hereditary breast cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology guidelines.
        Journal of Clinical Oncology. 2020; 38: 2080-2106https://doi.org/10.1200/JCO.20.00299
        • Villarreal-Garza C.
        • Weitzel J.N.
        • Llacuachaqui M.
        • Sifuentes E.
        • Magallanes-Hoyos M.C.
        • Gallardo L.
        • Narod S.A.
        The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer.
        Breast Cancer Research and Treatment. 2015; 150: 389-394https://doi.org/10.1007/s10549-015-3312-8
        • Waimey K.E.
        • Smith B.M.
        • Confino R.
        • Jeruss J.S.
        • Pavone M.E.
        Understanding fertility in young female cancer patients.
        Journal of Women’s Health. 2015; 24: 812-818https://doi.org/10.1089/jwh.2015.5194
        • Werner-Lin A.
        Beating the biological clock: The compressed family life cycle of young women with BRCA gene alterations.
        Social Work in Health Care. 2008; 47: 416-437https://doi.org/10.1080/00981380802173509
        • Werner-Lin A.
        • Rubin L.R.
        • Doyle M.
        • Stern R.
        • Savin K.
        • Hurley K.
        • Sagi M.
        “My funky genetics”: BRCA1/2 mutation carriers’ understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies.
        Families, Systems, & Health. 2012; 30: 166-180https://doi.org/10.1037/a0028434
        • Wong E.S.Y.
        • Shekar S.
        • Met-Domestici M.
        • Chan C.
        • Sze M.
        • Yap Y.S.
        • Lee A.S.G.
        Inherited breast cancer predisposition in Asians: Multigene panel testing outcomes from Singapore.
        NPJ Genomic Medicine. 2016; 1 (Article 15003)https://doi.org/10.1038/npjgenmed.2015.3
        • Woodson A.H.
        • Muse K.I.
        • Lin H.
        • Jackson M.
        • Mattair D.N.
        • Schover L.
        • Litton J.K.
        Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.
        Oncologist. 2014; 19: 797-804https://doi.org/10.1634/theoncologist.2014-0057

      Biography

      Elizabeth Skrovanek, BSN, RN, is a PhD candidate at the University of Pittsburgh School of Nursing, Pittsburgh, PA.

      Biography

      Jacqueline Dunbar-Jacob, PhD, RN, FAAN, is Dean of the School of Nursing and adjunct faculty in the Departments of Psychology, Epidemiology, and Occupational Therapy, University of Pittsburgh, Pittsburgh, PA.

      Biography

      Colleen Dunwoody, MS, RN, is a research associate at the University of Pittsburgh School of Nursing, Pittsburgh, PA.

      Biography

      Susan Wesmiller, PhD, RN, is an associate professor at the University of Pittsburgh School of Nursing, Pittsburgh, PA.